296 related articles for article (PubMed ID: 16927633)
1. A retrospective epidemiological and etiological study of metabolic disorders in children with cardiomyopathies.
Wang SM; Hou JW; Lin JL
Acta Paediatr Taiwan; 2006; 47(2):83-7. PubMed ID: 16927633
[TBL] [Abstract][Full Text] [Related]
2. Review: Metabolic cardiomyopathy and conduction system defects in children.
Gilbert-Barness E
Ann Clin Lab Sci; 2004; 34(1):15-34. PubMed ID: 15038665
[TBL] [Abstract][Full Text] [Related]
3. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy.
Helton E; Darragh R; Francis P; Fricker FJ; Jue K; Koch G; Mair D; Pierpont ME; Prochazka JV; Linn LS; Winter SC
Pediatrics; 2000 Jun; 105(6):1260-70. PubMed ID: 10835067
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic and genetic investigations in childhood cardiomyopathies].
Bonnet D; Rustin P; Rötig A; de Lonlay P; Viot G; Munnich A; Sidi D
Arch Mal Coeur Vaiss; 1999 Nov; 92(11):1509-14. PubMed ID: 10598230
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular involvement in metabolic diseases.
Gilbert-Barness E
Pediatr Pathol Mol Med; 2002; 21(2):93-136. PubMed ID: 11942539
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.
Scaglia F; Towbin JA; Craigen WJ; Belmont JW; Smith EO; Neish SR; Ware SM; Hunter JV; Fernbach SD; Vladutiu GD; Wong LJ; Vogel H
Pediatrics; 2004 Oct; 114(4):925-31. PubMed ID: 15466086
[TBL] [Abstract][Full Text] [Related]
7. The role of L-carnitine in pediatric cardiomyopathy.
Winter S; Jue K; Prochazka J; Francis P; Hamilton W; Linn L; Helton E
J Child Neurol; 1995 Nov; 10 Suppl 2():S45-51. PubMed ID: 8576569
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyopathies in children with neuromuscular disorders.
Malcić I; Barisić N; Brzović Z; Pazanin L; Senecić I
Neurol Croat; 1991; 40(4):221-30. PubMed ID: 1751640
[TBL] [Abstract][Full Text] [Related]
9. [Apparently idiopathic primary myocardiopathies in children. The role of metabolic etiology].
Lombes A; Hervé F; Ogier H; Pellet A; Sidi D; Villain E; Kachaner J; Charpentier C; Paturneau-Jouas M; Fardeau M
Arch Fr Pediatr; 1987 Oct; 44(8):569-78. PubMed ID: 3442458
[TBL] [Abstract][Full Text] [Related]
10. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
Giordano C; D'Amati G
Pathologica; 2005 Dec; 97(6):361-8. PubMed ID: 16619977
[TBL] [Abstract][Full Text] [Related]
11. [Familial cardiomyopathy caused by carnitine deficiency].
Maingourd Y; Goldfarb A; Bieth R; Caron FM; Gontier MF; Krim G; Kremp O
Arch Mal Coeur Vaiss; 1986 Oct; 79(11):1650-4. PubMed ID: 3103576
[TBL] [Abstract][Full Text] [Related]
12. Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic.
Gimeno JR; Lacunza J; García-Alberola A; Cerdán MC; Oliva MJ; García-Molina E; López-Ruiz M; Castro F; González-Carrillo J; de la Morena G; Valdés M
Am J Cardiol; 2009 Aug; 104(3):406-10. PubMed ID: 19616675
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyopathy in children.
Gilbert-Barness E; Marshall RJ
W V Med J; 2000; 96(1):352-6. PubMed ID: 10734798
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
[TBL] [Abstract][Full Text] [Related]
15. [Carnitine-deficient cardiomyopathy].
Kádár K; Melegh B; Szendrei E; Herczegfalvi A
Orv Hetil; 1994 Feb; 135(9):473-4. PubMed ID: 8139852
[TBL] [Abstract][Full Text] [Related]
16. [Cardiomyopathy caused by carnitine deficiency].
Vikre-Jørgensen J
Ugeskr Laeger; 1993 Oct; 155(42):3390-2. PubMed ID: 8259632
[TBL] [Abstract][Full Text] [Related]
17. [Congestive cardiomyopathies in children. Natural history and studies].
Cloutier A; Boutet M; Guay JM; Delisle G
Ann Cardiol Angeiol (Paris); 1986 Jun; 35(6):299-303. PubMed ID: 3777820
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with establishing a causal diagnosis for children with cardiomyopathy.
Cox GF; Sleeper LA; Lowe AM; Towbin JA; Colan SD; Orav EJ; Lurie PR; Messere JE; Wilkinson JD; Lipshultz SE
Pediatrics; 2006 Oct; 118(4):1519-31. PubMed ID: 17015543
[TBL] [Abstract][Full Text] [Related]
19. [Clinical presentation and therapeutic outcomes of carnitine deficiency-induced cardiomyopathy].
Fu LJ; Chen SB; Han LS; Guo Y; Zhao PJ; Zhu M; Li F; Huang MR
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):929-34. PubMed ID: 23324152
[TBL] [Abstract][Full Text] [Related]
20. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities.
van der Beek NA; Soliman OI; van Capelle CI; Geleijnse ML; Vletter WB; Kroos MA; Reuser AJ; Frohn-Mulder IM; van Doorn PA; van der Ploeg AT
J Neurol Sci; 2008 Dec; 275(1-2):46-50. PubMed ID: 18757064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
